Answers are grounded in this paper and cite their sources.
Case report demonstrates a fibroblastic low-grade endometrial stromal sarcoma misdiagnosed as an inflammatory pseudotumor in a young female, highlighting crucial diagnostic pitfalls.
The World Health Organization currently divides endometrial stromal sarcomas into 4 different entities, based on their clinical and pathological features: endometrial stromal nodule, low-grade endometrial stromal sarcomas (LG-ESS), High-grade endometrial stromal sarcomas, and undifferentiated uterine sarcoma. The fibroblastic variant of LG-ESS is rare and is usually made of small tumoral cells of oval to fusiform shape, demonstrating low cytologic atypia and low mitotic activity, which can lead to confusion with a benign myofibroblastic proliferation. We hereby report a rare case of a fibroblastic variant of LG-ESS in a 37-year-old woman presenting abundant metrorrhagia, which was initially misdiagnosed as an inflammatory pseudotumor before proofreading in our laboratory, along with a review of a histological and immunohistochemical findings, aiming to help pathologists avoid this diagnosis pitfall.
No takes yet. Share an insight, caveat, or question.
Haloui et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: